Published in J Mol Recognit on August 28, 2006
Smart self-assembled hybrid hydrogel biomaterials. Angew Chem Int Ed Engl (2012) 1.03
HIV-1 evades antibody-mediated neutralization through conformational masking of receptor-binding sites. Nature (2002) 9.62
Small-molecule inhibitors of HIV-1 entry block receptor-induced conformational changes in the viral envelope glycoproteins. Proc Natl Acad Sci U S A (2004) 2.44
Efficacy of duloxetine on cognition, depression, and pain in elderly patients with major depressive disorder: an 8-week, double-blind, placebo-controlled trial. Am J Psychiatry (2007) 1.78
Antibody binding is a dominant determinant of the efficiency of human immunodeficiency virus type 1 neutralization. J Virol (2006) 1.23
Efficacy of duloxetine and selective serotonin reuptake inhibitors: comparisons as assessed by remission rates in patients with major depressive disorder. J Clin Psychopharmacol (2007) 1.20
Optical gain and stimulated emission in periodic nanopatterned crystalline silicon. Nat Mater (2005) 1.14
Polyethylene glycol-superoxide dismutase, a conjugate in search of exploitation. Adv Drug Deliv Rev (2002) 1.14
Health technology assessment and its role in the future development of the Indian healthcare sector. Perspect Clin Res (2012) 1.11
Structural determinants for affinity enhancement of a dual antagonist peptide entry inhibitor of human immunodeficiency virus type-1. J Med Chem (2008) 1.07
Cell-free HIV-1 virucidal action by modified peptide triazole inhibitors of Env gp120. ChemMedChem (2011) 1.07
Anti-cancer PEG-enzymes: 30 years old, but still a current approach. Adv Drug Deliv Rev (2007) 1.06
Enhanced EGFR inhibition and distinct epitope recognition by EGFR antagonistic mAbs C225 and 425. Cancer Biol Ther (2008) 1.06
The active core in a triazole peptide dual-site antagonist of HIV-1 gp120. ChemMedChem (2010) 1.05
Antiviral breadth and combination potential of peptide triazole HIV-1 entry inhibitors. Antimicrob Agents Chemother (2011) 1.03
Salivary agglutinin inhibits HIV type 1 infectivity through interaction with viral glycoprotein 120. AIDS Res Hum Retroviruses (2003) 1.01
HIV envelope binding by macrophage-expressed gp340 promotes HIV-1 infection. J Immunol (2008) 0.99
Site-specific pegylation of G-CSF by reversible denaturation. Bioconjug Chem (2007) 0.94
Interleukin-5 receptor subunit oligomerization and rearrangement revealed by fluorescence resonance energy transfer imaging. J Biol Chem (2008) 0.87
Fabrication of anodic aluminium oxide templates on curved surfaces. Nanotechnology (2007) 0.87
A recombinant allosteric lectin antagonist of HIV-1 envelope gp120 interactions. Proteins (2007) 0.87
Asymmetric usage of antagonist charged residues drives interleukin-5 receptor recruitment but is insufficient for receptor activation. Biochemistry (2006) 0.86
Trojan-horse nanotube on-command intracellular drug delivery. Nano Lett (2012) 0.85
HIV-1 Env gp120 structural determinants for peptide triazole dual receptor site antagonism. Proteins (2012) 0.85
Solid-state nanopore detection of protein complexes: applications in healthcare and protein kinetics. Small (2012) 0.84
Site-directed enzymatic PEGylation of the human granulocyte colony-stimulating factor. FEBS J (2009) 0.84
Kinetic interaction analysis of human interleukin 5 receptor alpha mutants reveals a unique binding topology and charge distribution for cytokine recognition. J Biol Chem (2003) 0.84
Expression, purification, and characterization of recombinant cyanovirin-N for vaginal anti-HIV microbicide development. Protein Expr Purif (2005) 0.84
Increasing efficiency of photoelectronic conversion by encapsulation of photosynthetic reaction center proteins in arrayed carbon nanotube electrode. Langmuir (2008) 0.83
Click chemistry in peptide-based drug design. Molecules (2013) 0.82
Slow-dissociation effect of common signaling subunit beta c on IL5 and GM-CSF receptor assembly. Cytokine (2008) 0.82
Cytokine recognition by human interleukin 5 receptor. Vitam Horm (2005) 0.81
Nanoneedle method for high-sensitivity low-background monitoring of protein activity. Langmuir (2008) 0.81
Broad tuning of whispering-gallery modes in silicon microdisks. Opt Express (2010) 0.81
Chimeric Cyanovirin-MPER recombinantly engineered proteins cause cell-free virolysis of HIV-1. Antimicrob Agents Chemother (2013) 0.80
Receptor epitope usage by an interleukin-5 mimetic peptide. J Biol Chem (2005) 0.79
Structure-based design of mimetics for granulocyte-macrophage colony stimulating factor (GM-CSF). Curr Pharm Des (2002) 0.79
Selective alkylation and acylation of alpha and epsilon amino groups with PEG in a somatostatin analogue: tailored chemistry for optimized bioconjugates. Bioconjug Chem (2002) 0.79
Multivalent and flexible PEG-nitrilotriacetic acid derivatives for non-covalent protein pegylation. Pharm Res (2011) 0.78
Cyclic peptide interleukin 5 antagonists mimic CD turn recognition epitope for receptor alpha. Biopolymers (2004) 0.78
Recruitment pharmacophore for interleukin 5 receptor alpha antagonism. Biopolymers (2007) 0.78
Treatment of venous thromboembolism - effects of different therapeutic strategies on bleeding and recurrence rates and considerations for future anticoagulant management. Thromb J (2012) 0.78
Synthesis of diamond nanowires using atmospheric-pressure chemical vapor deposition. Nano Lett (2010) 0.77
Subwavelength silicon microcavities. Opt Express (2009) 0.77
Computational Evaluation of HIV-1 gp120 Conformations of Soluble Trimeric gp140 Structures as Targets for de Novo Docking of First- and Second-Generation Small-Molecule CD4 Mimics. J Chem Inf Model (2016) 0.77
Evaluation of metal-nanowire electrical contacts by measuring contact end resistance. Nanotechnology (2012) 0.77
Structure-based rationale for interleukin 5 receptor antagonism. Curr Pharm Des (2008) 0.76
Diamond nanowire--a challenge from extremes. Nanoscale (2012) 0.76
Proteins, recognition networks and developing interfaces for macromolecular biosensing. J Mol Recognit (2004) 0.76
Biosensor analysis of receptor-ligand interactions. Methods Mol Biol (2004) 0.75
Slow light and band gaps in metallodielectric cylinder arrays. Opt Express (2009) 0.75
Molecular weight effects on the phase-change-enhanced temperature coefficient of resistance in carbon nanotube/poly(N-isopropylacrylamide) composites. Nanotechnology (2015) 0.75
MRI findings of neutrophilic fasciitis in a patient with acute febrile neutrophilic dermatosis (Sweet's syndrome). Skeletal Radiol (2011) 0.75
Wiring efficiency of a metallizable DNA linker for site-addressable nanobioelectronic assembly. Nanotechnology (2007) 0.75
Reflectivity spectra and colors of porous anodic aluminum oxide containing silver nanoparticles by plasmonic absorption. J Nanosci Nanotechnol (2012) 0.75
DNA-programmable multiplexing for scalable, renewable redox protein bio-nanoelectronics. Bioelectrochemistry (2008) 0.75
Chemical optimization of macrocyclic HIV-1 inactivators for improving potency and increasing the structural diversity at the triazole ring. Org Biomol Chem (2017) 0.75
Wideband tunable mid-infrared cross polarization converter using rectangle-shape perforated graphene. Opt Express (2016) 0.75
Enhanced thermoelectric power in nanopatterned carbon nanotube film. Nanotechnology (2012) 0.75
Broadband and highly absorbing multilayer structure in mid-infrared. Appl Opt (2016) 0.75
Continuous-wave subwavelength microdisk lasers at λ = 1.53 µm. Opt Express (2010) 0.75
A protein engineering approach differentiates the functional importance of carbohydrate moieties of interleukin-5 receptor α. Biochemistry (2011) 0.75
Coiled coil miniprotein randomization on phage leads to charge pattern mimicry of the receptor recognition determinant of interleukin 5. J Mol Recognit (2002) 0.75